Faculty Opinions recommendation of Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group Study.

Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2021.04.015 ◽

2021 ◽

Author(s):

Danny Rischin ◽

Madeleine King ◽

Lizbeth Kenny ◽

Sandro Porceddu ◽

Christopher Wratten ◽

...

Keyword(s):

Radiation Therapy ◽

Randomized Trial ◽

Radiation Oncology ◽

Oropharyngeal Cancer ◽

Low Risk ◽

Oncology Group ◽

Oncology Group Study ◽

Faculty Opinions recommendation of Randomised trial of radiotherapy with weekly cisplatin or cetuximab in low risk HPV associated oropharyngeal cancer (TROG 12.01) - a Trans-Tasman Radiation Oncology Group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.740246443.793586289 ◽

2021 ◽

Author(s):

Melvin Chua

Keyword(s):

Radiation Oncology ◽

Oropharyngeal Cancer ◽

Randomised Trial ◽

Low Risk ◽

Oncology Group ◽

Oncology Group Study ◽

Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial – A Trans-Tasman Radiation Oncology Group study

Oral Oncology ◽

10.1016/j.oraloncology.2020.104988 ◽

2020 ◽

Vol 110 ◽

pp. 104988

Author(s):

Richard J. Young ◽

Benjamin Solomon ◽

June Corry ◽

Christopher Angel ◽

Lizbeth Kenny ◽

...

Keyword(s):

Human Papilloma Virus ◽

Radiation Oncology ◽

Oropharyngeal Cancer ◽

Oncology Group ◽

Cancer Trial ◽

Papilloma Virus ◽

Oncology Group Study ◽

Human Papilloma Virus Status ◽

Radiation Therapy and Chemotherapy Results in Elderly Patients With Stage III Non-Small Cell Lung Cancer: Turkish Thoracic Radiation Oncology Group Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.1802 ◽

2016 ◽

Vol 96 (2) ◽

pp. E467

Author(s):

S. Akyurek ◽

B.S. Ozdemir ◽

F. Sert ◽

D. Yalman ◽

G. Yavas ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Elderly Patients ◽

Radiation Oncology ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study ◽

Thoracic Radiation ◽

Erratum to Ringash J, Fisher R, Peters L, et al. Effect of p16 status on the quality-of-life experience during chemoradiation for locally advanced oropharyngeal cancer: a substudy of randomized trial trans-Tasman radiation oncology group (TROG) 02.02 (HeadSTART). Int J Radiat Oncol Biol Phys 2017;97:678-686.

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.05.042 ◽

2017 ◽

Vol 99 (1) ◽

pp. 244

Keyword(s):

Quality Of Life ◽

Randomized Trial ◽

Radiation Oncology ◽

Radiat Oncol Biol Phys ◽

Oropharyngeal Cancer ◽

Life Experience ◽

Locally Advanced ◽

Oncology Group ◽

Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.03.017 ◽

2017 ◽

Vol 97 (4) ◽

pp. 678-686 ◽

Cited By ~ 20

Author(s):

Jolie Ringash ◽

Richard Fisher ◽

Lester Peters ◽

Andy Trotti ◽

Brian O'Sullivan ◽

...

Keyword(s):

Quality Of Life ◽

Randomized Trial ◽

Radiation Oncology ◽

Oropharyngeal Cancer ◽

Life Experience ◽

Locally Advanced ◽

Oncology Group ◽

Acute toxicity and cost analysis of a phase III randomized trial of accelerated and conventional radiotherapy for squamous carcinoma of the head and neck: A Trans-Tasman Radiation Oncology Group study

Australasian Radiology ◽

10.1046/j.1440-1673.1999.00718.x ◽

1999 ◽

Vol 43 (4) ◽

pp. 487-494 ◽

Cited By ~ 9

Author(s):

M Poulsen ◽

J Denham ◽

N Spry ◽

D Lamb ◽

L Peters ◽

...

Keyword(s):

Acute Toxicity ◽

Cost Analysis ◽

Randomized Trial ◽

Radiation Oncology ◽

Squamous Carcinoma ◽

Phase Iii ◽

Oncology Group ◽

Conventional Radiotherapy ◽

Oncology Group Study ◽

Trans Tasman Radiation Oncology Group (TROG) 02.03 phase III trial: Concurrent weekly cisplatin and radiation therapy in localized muscle- invasive bladder cancer—Compliance, toxicity, QOL, and overall results.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.4543 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 4543-4543

Author(s):

Nirdosh Kumar Gogna ◽

Peter O'Brien ◽

Nigel Spry ◽

Sandra Turner ◽

John Matthews ◽

...

Keyword(s):

Bladder Cancer ◽

Radiation Therapy ◽

Radiation Oncology ◽

Phase Iii ◽

Oncology Group ◽

Muscle Invasive Bladder Cancer ◽

Phase Iii Trial ◽

Muscle Invasive ◽

Faculty Opinions recommendation of Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726379894.793530806 ◽

2017 ◽

Author(s):

Sandra Nuyts ◽

Sarah Deschuymer

Keyword(s):

Quality Of Life ◽

Randomized Trial ◽

Radiation Oncology ◽

Oropharyngeal Cancer ◽

Life Experience ◽

Locally Advanced ◽

Oncology Group ◽

Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.01.008 ◽

2015 ◽

Vol 92 (1) ◽

pp. 32-39 ◽

Cited By ~ 75

Author(s):

Lena Specht ◽

Bouthaina Dabaja ◽

Tim Illidge ◽

Lynn D. Wilson ◽

Richard T. Hoppe

Keyword(s):

Radiation Therapy ◽

Radiation Oncology ◽

Oncology Group ◽

Cutaneous Lymphomas ◽